4//SEC Filing
SANDERS MACHELLE 4
Accession 0000882796-25-000017
CIK 0000882796other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:07 PM ET
Size
4.7 KB
Accession
0000882796-25-000017
Insider Transaction Report
Form 4
SANDERS MACHELLE
Director
Transactions
- Sale
Common Stock
2025-11-13$7.14/sh−9,600$68,544→ 30,642 total
Footnotes (1)
- [F1]These shares were sold pursuant to a plan adopted by the Reporting Person on August 14, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001718020
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:07 PM ET
- Size
- 4.7 KB